Diagnostic Criteria for Vascular Cognitive Disorders: A VASCOG Statement
Open accessAbstract
BACKGROUND: Several sets of diagnostic criteria have been published for vascular dementia since the 1960s. The continuing ambiguity in vascular dementia definition warrants a critical reexamination. METHODS: Participants at a special symposium of the International Society for Vascular Behavioral and Cognitive Disorders (VASCOG) in 2009 critiqued the current criteria. They drafted a proposal for a new set of criteria, later reviewed through multiple drafts by the group, including additional experts and the members of the Neurocognitive Disorders Work Group of the fifth revision of Diagnostic and Statistical Manual (DSM-5) Task Force. RESULTS: Cognitive disorders of vascular etiology are a heterogeneous group of disorders with diverse pathologies and clinical manifestations, discussed broadly under the rubric of vascular cognitive disorders (VCD). The continuum of vascular cognitive impairment is recognized by the categories of Mild Vascular Cognitive Disorder, and Vascular Dementia or Major Vascular Cognitive Disorder. Diagnostic thresholds are defined. Clinical and neuroimaging criteria are proposed for establishing vascular etiology. Subtypes of VCD are described, and the frequent cooccurrence of Alzheimer disease pathology emphasized. CONCLUSIONS: The proposed criteria for VCD provide a coherent approach to the diagnosis of this diverse group of disorders, with a view to stimulating clinical and pathologic validation studies. These criteria can be harmonized with the DSM-5 criteria such that an international consensus on the criteria for VCD may be achieved.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 69 cited sources checked · 0 supported · 0 flagged
- Interpretationnone given
DTI abnormalities are not delineated well enough at present to be incorporated into diagnostic criteria.
“Abnormalities on DTI are, however, not delineated well enough at present to be incorporated into diagnostic criteria.”
Quote in the paperSubstantial claim - Premisecitation
The preponderance of cognitive disturbance in vascular cognitive disorders is in processing speed and frontal-executive functions, manifesting as slowed information processing, poorer working memory, and reduced set-shifting.
“A considerable body of literature has concluded that the preponderance of disturbance in vascular cognitive disorders is in processing speed and frontal-executive functions, manifesting as slowed information processing, poorer working memory and reduced set-shifting ability.10,14”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [10] Hachinski V Iadecola C Petersen RC National Institute of Neurological disorders and Stroke - Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards Stroke 2006 37 2220 2241 16917086 source
Not checked in the free run.
- cites [14] Looi JCL Sachdev PS Differentiation of vascular dementia from AD on neuropsychological tests Neurology 1999 53 670 678 10489025 source
Not checked in the free run.
- Premisecitation
Evidence from clinical and pathological data suggests that the majority of WMLs in the brains of older people are ischemic in origin.
“While the differential diagnosis is long, there is evidence from clinical and pathological data to suggest that the majority of these lesions in the brains of older people are ischemic in origin.51”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [51] Pantoni L Garcia JH Pathogenesis of leukoaraiosis: a review Stroke 1997 28 652 659 9056627 source
Not checked in the free run.
- Premisecitation
The severity of cognitive deficits after subarachnoid hemorrhage is related to the severity of the hemorrhage.
“their severity is related to the severity of SAH,62”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [62] Hunt WE Clinical assessment of SAH J Neurosurg 1983 59 550 551 6886772 source
Not checked in the free run.
- Premisecitation
Cognitive impairment in VCD lies on a continuum from normal functioning to dementia.
“The concept of VCI recognizes that cognitive impairment in VCD is on a continuum from normal functioning to dementia.12”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [12] Hachinski VC Bowler JV Vascular dementia Neurology 1993 43 2159 2160 8414002 source
Not checked in the free run.
- Premisecitation
For VaD or Major VCD, the additional presence of one or more lacunes is necessary when extensive WMLs are present.
“For VaD (or Major VCD), the additional presence of one or more lacunes is necessary,8 which is not uncommon in individuals with extensive WMLs.17”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [8] Hachinski VC Iliff LD Zilkha E Cerebral blood flow in dementia Arch Neurol 1975 32 632 637 1164215
Not checked in the free run.
- Interpretationreasoning
Memory impairment is not a prerequisite for the diagnosis of vascular cognitive disorders.
“A significant departure from most previous definitions of dementia is that memory impairment is not a pre-requisite for the diagnosis.”
Quote in the paperSubstantial claim - Premisecitation
DTI has shown that white matter appearing normal on T2-weighted imaging may have abnormal anisotropy or diffusivity related to neuropathology and cognitive function.
“With the development of newer MRI techniques such as diffusion tensor imaging (DTI), it has been demonstrated that white matter which appears normal on T2-weighted imaging may also have abnormal anisotropy or diffusivity which relates to neuropathology59 and may have relevance for cognitive function.60”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [59] Brown WR Moody DM Thore CR Vascular dementia in leukoaraiosis may be a consequence of capillary loss not only in the lesions, but in normal-appearing white matter and cortex as well J Neurol Sci 2007 257 62 66 17320909 PMC1989116 source
Not checked in the free run.
- cites [60] Nitkunan A Barrick TR Charlton RA Multimodal MRI in cerebral small vessel disease: its relationship with cognition and sensitivity to change over time Stroke 2008 39 1999 2005 18436880 source
Not checked in the free run.
- Premisecitation
Microbleeds associated with hypertension are seen in the deep nuclei and brainstem.
“Microbleeds associated with hypertension are seen in the deep nuclei and brainstem and those with AD are generally lobar in location.67,68”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [67] Goos JD Kester MI Barkhof F Patients with Alzheimer disease with multiple microbleeds: relation with cerebrospinal fluid biomarkers and cognition Stroke 2009 40 3455 3460 19762705 source
Not checked in the free run.
- cites [68] Cordonnier C Al-Shahi Salman R Wardlaw J Spontaneous brain microbleeds: systematic review, subgroup analyses and standards for study design and reporting Brain 2007 130 1988 2003 17322562 source
Not checked in the free run.
- Premisecitation
Vascular cognitive disorder is associated with cortical and subcortical microbleeds.
“VCD has also been associated with cortical and subcortical microbleeds, which may be related to hypertension or CAA.66”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [66] Werring DJ Gregoire SM Cipolotti L Cerebral microbleeds and vascular cognitive impairment J Neurol Sci 2010 299 131 135 20850134 source
Not checked in the free run.
- Premisecitation
Vascular risk factors increase the risk of cognitive disorders.
“A number of ‘vascular’ risk factors, variably referred to as ‘cardiovascular’ or ‘cerebrovascular’, have been identified as increasing the risk of cognitive disorders.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [24] Gorelick PB Scuteri A Black SE Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke 2011 42 2672 2713 21778438 PMC3778669 source
Not checked in the free run.
- Interpretationcitation
Post-stroke dementia is generally a combination of Alzheimer's disease and vascular dementia.
“suggesting that the latter is generally a combination of AD and vascular dementia.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [72] Lee JH Kim Sh Kim GH Identification of pure subcortical vascular dementia using 11C-Pittsburgh compound B Neurology 2011 77 18 25 21593437 source
Not checked in the free run.
- cites [73] Mok V Leung EY Chu W Pittsburgh compound B binding in poststroke dementia J Neurol Sci 2010 290 135 137 20056250 source
Not checked in the free run.
- Premisecitation
Multiple hemorrhages or hemorrhagic infarcts are often associated with vascular cognitive disorder.
“Multiple hemorrhages or hemorrhagic infarcts are often associated with VCD, the common causes being sporadic or hereditary conditions associated with cerebral amyloid angiopathy (CAA)64 and other genetic disorders,65 although hypertension may have a role.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [64] Attems J Jellinger K Thal DR Review: sporadic cerebral amyloid angiopathy Neuropathol Appl Neurobiol 2011 37 75 93 20946241 source
Not checked in the free run.
- cites [65] Yamamoto Y Craggs L Baumann M Molecular genetics and pathology of hereditary small vessel diseases of the brain Neuropathol Appl Neurobiol 2011 37 94 113 21062344 source
Not checked in the free run.
- Premisecitation
Amyloid imaging has been used to support the diagnosis of pure subcortical vascular dementia.
“Amyloid imaging has recently been used to support the diagnosis of pure subcortical vascular dementia72 as well as post-stroke dementia,73”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [72] Lee JH Kim Sh Kim GH Identification of pure subcortical vascular dementia using 11C-Pittsburgh compound B Neurology 2011 77 18 25 21593437 source
Not checked in the free run.
- Premisecitation
Cortical and subcortical microbleeds may be related to hypertension or cerebral amyloid angiopathy.
“VCD has also been associated with cortical and subcortical microbleeds, which may be related to hypertension or CAA.66”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [66] Werring DJ Gregoire SM Cipolotti L Cerebral microbleeds and vascular cognitive impairment J Neurol Sci 2010 299 131 135 20850134 source
Not checked in the free run.
- Premisecitation
Microbleeds associated with Alzheimer's disease are generally lobar in location.
“Microbleeds associated with hypertension are seen in the deep nuclei and brainstem and those with AD are generally lobar in location.67,68”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [67] Goos JD Kester MI Barkhof F Patients with Alzheimer disease with multiple microbleeds: relation with cerebrospinal fluid biomarkers and cognition Stroke 2009 40 3455 3460 19762705 source
Not checked in the free run.
- cites [68] Cordonnier C Al-Shahi Salman R Wardlaw J Spontaneous brain microbleeds: systematic review, subgroup analyses and standards for study design and reporting Brain 2007 130 1988 2003 17322562 source
Not checked in the free run.
- Premisecitation
Amyloid imaging has been used to support the diagnosis of post-stroke dementia.
“Amyloid imaging has recently been used to support the diagnosis of pure subcortical vascular dementia72 as well as post-stroke dementia,73”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [73] Mok V Leung EY Chu W Pittsburgh compound B binding in poststroke dementia J Neurol Sci 2010 290 135 137 20056250 source
Not checked in the free run.
- Premisecitation
Subdural hemorrhage is an uncommon cause of cognitive disorder.
“Subdural hemorrhage is an uncommon cause of cognitive disorder, with reports that older individuals with chronic SH have cognitive deficits in about one in two cases,61”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [61] Starkstein SE Jorge R Capizzano AA Uncommon causes of cerebrovascular dementia Int Psychogeriatr 2005 17 S51 S64 16240483 source
Not checked in the free run.
- Premisecitation
The clinical expression of major or mild cognitive disorder depends on the severity of Alzheimer's pathology and the location and type of vascular lesions, with cortical microinfarcts and thalamic and basal ganglia lacunar infarcts often implicated.
“The clinical expression of major or mild cognitive disorder will depend upon the severity of AD pathology as well as the location and type of vascular lesions, with cortical microinfarcts and thalamic and basal ganglia lacunar infarcts often being implicated.82”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [82] Gold G Giannakopoulos P Herrmann FR Identification of Alzheimer and vascular lesion thresholds for mixed dementia Brain 2007 130 2830 2836 17878206
Not checked in the free run.
- Premisecitation
Vascular risk factors also promote Alzheimer-type pathology in the brain.
“The increasing evidence that the so-called vascular risk factors also promote Alzheimer-type pathology in the brain suggests that pure VCD or AD are far less common than previously thought.83”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [83] Viswanathan A Rocca WA Tzourio C Vascular risk factors and dementia: how to move forward? Neurology 2009 72 368 374 19171835 PMC2677504
Not checked in the free run.
- Interpretationreasoning
Cerebrospinal fluid Alzheimer's markers and amyloid positron emission tomography may help determine Alzheimer's disease as the main or contributory cause of cognitive disorder.
“These, along with amyloid imaging using positron emission tomography (PET), may help determine AD as the main or contributory cause of the cognitive disorder.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [21] McKhann GM Knopman DS Chertkow H The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimers Dement 2011 7 263 269 21514250 PMC3312024 source
Not checked in the free run.
- cites [22] Albert MS Dekosky ST Dickson D The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimers Dement 2011 7 270 279 21514249 PMC3312027 source
Not checked in the free run.
- Premisecitation
Thalamic dementia is a special case of subcortical vascular cognitive disorder caused by thalamic infarctions with relatively little involvement of other brain structures.
“A special case of subcortical VCD is thalamic dementia, due to infarctions located in the thalamus with relatively little involvement of other brain structures.79”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [79] Carrera E Bogousslavsky J The thalamus and behavior: effects of anatomically distinct strokes Neurology 2006 66 1817 1823 16801643
Not checked in the free run.
- Premisecitation
Concurrent cerebrovascular disease is more common in Alzheimer's disease than in other neurodegenerative disorders.
“The concurrent presence of CVD is more common in AD than other neurodegenerative disorders, and has been noted to lower the threshold of diagnosis of dementia due to AD and α-synucleinopathies.81”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [81] Toledo JB Arnold SE Raible K Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer's Coordinating Centre Brain 2013 136 2697 2706 23842566 PMC3858112
Not checked in the free run.
- Interpretationcitation
Pure vascular cognitive disorder or pure Alzheimer's disease are far less common than previously thought.
“The increasing evidence that the so-called vascular risk factors also promote Alzheimer-type pathology in the brain suggests that pure VCD or AD are far less common than previously thought.83”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [83] Viswanathan A Rocca WA Tzourio C Vascular risk factors and dementia: how to move forward? Neurology 2009 72 368 374 19171835 PMC2677504
Not checked in the free run.
- Premisecitation
Concurrent cerebrovascular disease lowers the threshold for diagnosing dementia due to Alzheimer's disease and α-synucleinopathies.
“The concurrent presence of CVD is more common in AD than other neurodegenerative disorders, and has been noted to lower the threshold of diagnosis of dementia due to AD and α-synucleinopathies.81”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [81] Toledo JB Arnold SE Raible K Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer's Coordinating Centre Brain 2013 136 2697 2706 23842566 PMC3858112
Not checked in the free run.
- Premisecitation
Vascular cognitive disorder may be exclusively due to subcortical vascular lesions.
“It is now well-recognized that VCD may be exclusively due to subcortical vascular lesions, and various attempts have been made to characterize subcortical VCD.8,9,36”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [8] Hachinski VC Iliff LD Zilkha E Cerebral blood flow in dementia Arch Neurol 1975 32 632 637 1164215 source
Not checked in the free run.
- cites [9] Erkinjuntti T Inzitari D Pantoni L Research criteria for subcortical vascular dementia in clinical trials J Neural Transm Suppl 2000 59 23 30 10961414 source
Not checked in the free run.
- cites [36] Román GC Erkinjuntti T Wallin A Subcortical ischaemic vascular dementia Lancet Neurol 2002 1 426 436 12849365 source
Not checked in the free run.
- Premisecitation
Pure subcortical vascular cognitive disorder with a slowly progressive course that simulates Alzheimer's disease but lacks the characteristic brain amyloid burden of Alzheimer's disease has been documented.
“Pure subcortical VCD with a slowly progressive course that simulates AD but which does not have the characteristic brain amyloid burden of AD has recently been documented.71”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [71] Tartaglia MC Rosen HJ Miller BL Neuroimaging in dementia Neurotherapeutics 2011 8 82 92 21274688 PMC3026935 source
Not checked in the free run.
- Premisereasoning
Attempts to characterize and quantify vascular brain pathology and to harmonize criteria have not achieved general consensus.
“Some attempts have been made to characterize and quantify vascular brain pathology17,28,77 and to harmonize criteria,10 but have thus far not achieved general consensus.”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [17] Jellinger KA Morphologic diagnosis of "vascular dementia" - a critical update J Neurol Sci 2008 270 1 12 18455191 source
Not checked in the free run.
- cites [28] Kalaria RN Kenny RA Ballard CG Towards defining the neuropathological substrates of vascular dementia J Neurol Sci 2004 226 75 80 15537525 source
Not checked in the free run.
- cites [77] Deramecourt V Slade JY Oakley AE Staging and natural history of cerebrovascular pathology in dementia Neurology 2012 78 1043 1050 22377814 PMC3317531 source
Not checked in the free run.
- cites [10] Hachinski V Iadecola C Petersen RC National Institute of Neurological disorders and Stroke - Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards Stroke 2006 37 2220 2241 16917086 source
Not checked in the free run.
- Premisecitation
Suggested cerebrospinal fluid biomarkers of cerebrovascular disease include albumin index, sulfatide, neurofilament, and matrix metalloproteinases.
“Some suggested cerebrospinal fluid (CSF) biomarkers of cerebrovascular disease are the albumin index as a marker of damage to the blood-brain barrier, sulfatide for demyelination, neurofilament for axonal degeneration and matrix metalloproteinases for vascular disease.10”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [10] Hachinski V Iadecola C Petersen RC National Institute of Neurological disorders and Stroke - Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards Stroke 2006 37 2220 2241 16917086 source
Not checked in the free run.
- Interpretationreasoning
The heterogeneity of vascular pathology has made it difficult to establish validated criteria for vascular cognitive disorder.
“The heterogeneity of vascular pathology has made it difficult to establish validated criteria for VCD.”
Quote in the paperSubstantial claim
- May combine two claims. 18
- Classified as probably not a substantial claim. 6
May combine two claims.
PremisecitationEvidence for significant vascular pathology in the brain usually relies on CT or structural MRI, with MRI being more sensitive, especially if standardized protocols are followed.
“Evidence for significant vascular pathology in the brain usually relies on computed tomography (CT) or structural magnetic resonance imaging (MRI), with the latter being more sensitive, especially if the standardized protocols recommended by the harmonization group are followed.10”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [10] Hachinski V Iadecola C Petersen RC National Institute of Neurological disorders and Stroke - Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards Stroke 2006 37 2220 2241 16917086 source
Not checked in the free run.
May combine two claims.
PremisecitationVascular and neurodegenerative processes may interact, so risk factors for cerebrovascular disease also increase the risk of AD.
“Furthermore, there is increasing recognition that vascular and neurodegenerative processes may interact, so that risk factors for CVD also increase the risk of AD.20”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [20] Skoog I Vascular aspects in Alzheimer's disease J Neural Transm Suppl 2000 59 37 43 10961416 source
Not checked in the free run.
May combine two claims.
PremisereasoningVascular cognitive disorders are a heterogeneous group with varied pathologies and clinical presentations.
“Cognitive disorders of vascular etiology are a heterogeneous group of disorders with diverse pathologies and clinical manifestations, discussed broadly under the rubric of vascular cognitive disorders (VCD).”
- Also stated in: § 3.1. Criteria for vascular cognitive disorders (VCD) · plain
“The heterogeneity stems from the type of vascular lesion and the nature, extent and location of parenchymal injury.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [5] Chui HC Victoroff JI Margolin D Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer’s Disease Diagnostic and Treatment Centers Neurology 1992 42 473 480 1549205 source
Not checked in the free run.
- cites [10] Hachinski V Iadecola C Petersen RC National Institute of Neurological disorders and Stroke - Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards Stroke 2006 37 2220 2241 16917086 source
Not checked in the free run.
- cites [17] Jellinger KA Morphologic diagnosis of "vascular dementia" - a critical update J Neurol Sci 2008 270 1 12 18455191 source
Not checked in the free run.
- Also stated in: § 3.1. Criteria for vascular cognitive disorders (VCD) · plain
May combine two claims.
PremisecitationVascular brain damage can exist without evident cognitive impairment, and such asymptomatic individuals may be at increased risk of future decline.
“Vascular brain damage can exist without any evident cognitive impairment, and such asymtomatic individuals may be at an increased risk of future decline and are worthy of medical attention to prevent such decline.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [12] Hachinski VC Bowler JV Vascular dementia Neurology 1993 43 2159 2160 8414002 source
Not checked in the free run.
May combine two claims.
PremisecitationVaD is not a single disease but has diverse etiologies, only some of which have well-characterized clinical manifestations.
“Fifth, VaD is not one disease but rather has diverse etiologies, only some of which have well-characterized clinical manifestations.17”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [17] Jellinger KA Morphologic diagnosis of "vascular dementia" - a critical update J Neurol Sci 2008 270 1 12 18455191
Not checked in the free run.
May combine two claims.
PremisecitationThe commonly used VaD criteria sets differ substantially in their requirements, so prevalence estimates can vary by many orders of magnitude when applied to the same dataset.
“Fourth, the criteria sets differ significantly on the requirements for levels of cognitive impairment, number and location of strokes, neuroimaging abnormalities and neurological features, such that when applied to the same data set, the prevalence estimates can vary by many orders of magnitude.15,16”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [15] Wetterling T Kanitz RD Borgis KJ Comparison of different diagnostic criteria for vascular dementia (ADDTC, DSM-IV, ICD-10, NINDS-AIREN) Stroke 1996 27 30 36 8553399 source
Not checked in the free run.
- cites [16] Pohjasvaara T Erkinjuntti T Vataja R Dementia three months after stroke. Baseline frequency and effect of different definitions of dementia in the Helsinki Stroke Aging Memory Study (SAM) cohort Stroke 1997 28 785 792 9099197 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductreasoningThe proposed criteria were developed through a VASCOG symposium, multiple drafts, additional experts, and review by the DSM-5 Neurocognitive Disorders Work Group.
“Participants at a special symposium of the International Society for Vascular Behavioral and Cognitive Disorders (VASCOG) in 2009 critiqued the current criteria. They drafted a proposal for a new set of criteria, later reviewed through multiple drafts by the group, including additional experts and the members of the Neurocognitive Disorders Work Group of the DSM-5 Task Force.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationDemonstration of abnormalities on neuroimaging is critical for increased certainty in diagnosis, and lack of neuroimaging data can cause significant diagnostic inaccuracy by overlooking silent brain infarction and WMLs.
“The demonstration of abnormalities on neuroimaging is critical for increased certainty in the diagnosis, and the lack of neuroimaging data can result in significant diagnostic inaccuracy by overlooking silent brain infarction and WMLs.37”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [37] Tullberg M Fletcher E DeCarli C White matter lesions impair frontal lobe function regardless of their location Neurology 2004 63 246 253 15277616 PMC1893004 source
Not checked in the free run.
May combine two claims.
PremisecitationWMLs are highly prevalent in the brains of elderly and even middle-aged individuals, and the lesions must be extensive to be clinically significant.
“WMLs are highly prevalent in the brains of elderly and even middle-aged individuals,54,55 and the lesions have to be extensive to be clinically significant.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [54] Wen W Sachdev P The topography of white matter hyperintensities on brain MRI in healthy 60- to 64-year old individuals Neuroimage 2004 22 144 154 15110004 source
Not checked in the free run.
- cites [55] Wen W Sachdev P Li JJ White matter hyperintensities in the forties: Their prevalence and topography in an epidemiological sample aged 44–48 Hum Brain Mapp 2009 30 1155 1167 18465744 PMC6870596 source
Not checked in the free run.
May combine two claims.
PremisecitationMany older people with dementia have combined vascular and Alzheimer-type pathology, and the two pathologies have an additive effect on cognition.
“many older individuals with dementia suffer from a combination of vascular and Alzheimer-type pathology with an additive effect on cognition,19”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [19] Snowdon DA Greiner LH Mortimer JA Brain infarction and the clinical expression of Alzheimer’s disease: The nun study JAMA 1997 227 813 817 9052711 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationCognitive deficits occur in 19-62% of patients after subarachnoid hemorrhage.
“Cognitive deficits have been reported in 19–62% of patients following SAH,61”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [61] Starkstein SE Jorge R Capizzano AA Uncommon causes of cerebrovascular dementia Int Psychogeriatr 2005 17 S51 S64 16240483 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataThe criteria were discussed at the 5th and 6th VASCOG conferences before being finalized.
“The criteria were discussed at the 5th VASCOG conference in September 2011 in Lille, France and the 6th VASCOG conference in June 2013 in Toronto, Canada before being finalized.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationVaD is generally regarded as the second most common single cause of dementia after AD.
“while VaD is generally regarded as the second most common single cause of dementia after AD,18”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [18] Fratiglioni L Launer LJ Andersen K Incidence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group Neurology 2000 54 S10 S15 10854355
Not checked in the free run.
May combine two claims.
PremisecitationIn subarachnoid hemorrhage, older age, arterial vasospasm, delayed cerebral infarction, raised intracranial pressure, intraparenchymal and intraventricular hemorrhage, hydrocephalus, and aneurysm location are important factors for cognitive deficits.
“although other factors such as older age, the presence of arterial vasospasm and delayed cerebral infarction, increased intracranial pressure, intraparenchymal and intraventricular hemorrhages, hydrocephalus, and location of the aneurysm are all important.61”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [61] Starkstein SE Jorge R Capizzano AA Uncommon causes of cerebrovascular dementia Int Psychogeriatr 2005 17 S51 S64 16240483 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAmyloid imaging with radiolabeled Pittsburgh compound B has been proposed as a biomarker of Alzheimer's disease.
“More recently, the imaging of amyloid with compounds such as the radiolabeled Pittsburgh compound B (11C-PiB) has received much interest and been proposed as a biomarker of AD.21,22”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [21] McKhann GM Knopman DS Chertkow H The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimers Dement 2011 7 263 269 21514250 PMC3312024 source
Not checked in the free run.
- cites [22] Albert MS Dekosky ST Dickson D The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimers Dement 2011 7 270 279 21514249 PMC3312027 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAbout half of older individuals with chronic subdural hemorrhage have cognitive deficits.
“Subdural hemorrhage is an uncommon cause of cognitive disorder, with reports that older individuals with chronic SH have cognitive deficits in about one in two cases,61”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [61] Starkstein SE Jorge R Capizzano AA Uncommon causes of cerebrovascular dementia Int Psychogeriatr 2005 17 S51 S64 16240483 source
Not checked in the free run.
May combine two claims.
PremisecitationHypertension, diabetes, high cholesterol, and high homocysteine have been independently linked to increased risk of Alzheimer's disease, although the evidence is inconsistent.
“Risk factors such as hypertension, diabetes, high cholesterol and high homocysteine have been independently linked to an increased risk of Alzheimer’s disease although the evidence remains inconsistent.74–76”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [74] de la Torre JC Is Alzheimer’s disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics Lancet Neurol 2004 3 184 190 14980533 source
Not checked in the free run.
- cites [75] Hendrie HC Albert MS Butters MA The NIH cognitive and emotional health project. Report of the Critical Evaluation Study Committee Alzheimer Dement 2006 2 12 32 19595852 source
Not checked in the free run.
- cites [76] Purnell C Gao S Callahan CM Cardiovascular risk factors and incident Alzheimer disease: a systematic review of the literature Alzheimer Dis Assoc Disord 2009 23 1 10 18703981 PMC3689425 source
Not checked in the free run.
May combine two claims.
PremisecitationCommon causes of multiple hemorrhages or hemorrhagic infarcts in vascular cognitive disorder are sporadic or hereditary conditions linked to cerebral amyloid angiopathy and other genetic disorders, with hypertension possibly contributing.
“Multiple hemorrhages or hemorrhagic infarcts are often associated with VCD, the common causes being sporadic or hereditary conditions associated with cerebral amyloid angiopathy (CAA)64 and other genetic disorders,65 although hypertension may have a role.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [64] Attems J Jellinger K Thal DR Review: sporadic cerebral amyloid angiopathy Neuropathol Appl Neurobiol 2011 37 75 93 20946241 source
Not checked in the free run.
- cites [65] Yamamoto Y Craggs L Baumann M Molecular genetics and pathology of hereditary small vessel diseases of the brain Neuropathol Appl Neurobiol 2011 37 94 113 21062344 source
Not checked in the free run.
May combine two claims.
PremisecitationCognitive deficits in chronic subdural hemorrhage may be progressive and are not always reversible by surgical drainage.
“which may be progressive and not always reversible with surgical drainage.63”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [63] Ishikawa E Yanaka K Sugimoto K Reversible dementia in patients with chronic subdural hematomas J Neurosurg 2002 96 680 683 11990807 source
Not checked in the free run.
May combine two claims.
PremisecitationOther neuroimaging measures such as brain atrophy rate, hippocampal or mesial temporal atrophy, cerebral blood flow, and cerebral metabolic rate may be useful in differential diagnosis in some cases, but their status as Alzheimer's disease biomarkers is uncertain.
“Other neuroimaging to determine the rate of brain atrophy, hippocampal or mesial temporal atrophy, cerebral blood flow and cerebral metabolic rate may be useful in the differential diagnosis in some cases, but their status as biomarkers of AD is uncertain.22”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [22] Albert MS Dekosky ST Dickson D The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimers Dement 2011 7 270 279 21514249 PMC3312027 source
Not checked in the free run.
May combine two claims.
PremisecitationCerebrospinal fluid markers for Alzheimer's disease are better developed, with lower Aβ42 and elevated tau/phosphorylated-tau indicating Alzheimer's pathology.
“CSF markers for AD are, however, better developed, with lower levels of Aβ42 and elevated levels of tau/phosphorylated-tau being indicative of AD pathology.21,22”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [21] McKhann GM Knopman DS Chertkow H The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimers Dement 2011 7 263 269 21514250 PMC3312024 source
Not checked in the free run.
- cites [22] Albert MS Dekosky ST Dickson D The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimers Dement 2011 7 270 279 21514249 PMC3312027 source
Not checked in the free run.
May combine two claims.
PremisecitationCarotid intimal-medial thickness and arterial stiffness are associated with arterial ageing and may serve as risk markers of vascular cognitive disorder.
“Emerging markers include carotid intimal-medial thickness and arterial stiffness, which are associated with arterial ageing and may serve as risk markers of VCD.24”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [24] Gorelick PB Scuteri A Black SE Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke 2011 42 2672 2713 21778438 PMC3778669 source
Not checked in the free run.
May combine two claims.
PremisecitationPost-mortem examinations of older people with cognitive disorders usually show mixed pathologies, with vascular and Alzheimer-type pathology predominating, and other etiologies such as Lewy body disease also present.
“Post-mortem examinations of the brains of older people who had cognitive disorders in life usually reveal a combination of pathologies with vascular lesions and Alzheimer-type pathology predominating, but stigmata of other etiologies, such as Lewy body disease, are also present.80”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [80] Neuropathology Group of the Medical Research Council Cognitive Function, and Aging Study (MRC CFAS) Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales Lancet 2001 357 169 175 11213093
Not checked in the free run.
The paper relies on this without support.
The term dementia has increasingly become equated with AD in the popular mind.
“The term dementia has increasingly become equated with AD in the popular mind, even though AD accounts just over one-half of all cases of dementia.11”
The paper relies on this without support.
Potentially disease-modifying treatments may be more effective before the late stage identified by the VaD threshold.
“Yet potentially disease-modifying treatments may be more effective before this stage is reached.”
The paper relies on this without support.
The temporal relationship between cerebrovascular events and cognitive impairment is not difficult to establish clinically.
“This pattern is temporally related to cerebrovascular events of infarction, hemorrhage or vasculitis, and the temporal relationship is not difficult to establish clinically.”
The paper relies on this without support.
VCD with gradual onset and slow progression is generally due to small vessel disease leading to lesions in the white matter, basal ganglia, and/or thalamus.
“VCD with a gradual onset and slow progression is generally due to small vessel disease leading to lesions in the white matter, basal ganglia and/or thalamus.”
The paper relies on this without support.
Neuropsychiatric features are not specific to vascular etiology.
“As these neuropsychiatric features are not specific to vascular etiology, they are not considered to be core diagnostic features, yet may be the presenting symptoms.”
The paper relies on this without support.
No neuroimaging feature is pathognomonic of VCD.
“The findings are varied and there is no feature that is pathognomonic of VCD.”
The paper relies on this without support.
VCD can occur without evidence of brain infarcts.
“It is generally accepted that VCD can occur without evidence of brain infarcts, although the latter are usually present.”
The paper relies on this without support.
Focal WMLs visible only on T2-weighted MRI are unlikely to be significant enough to explain the development of a cognitive disorder.
“If the WMLs are focal and visible only on T2-weighted MRI, they are unlikely to be significant enough to explain the development of a cognitive disorder.”
The paper relies on this without support.
Subdural hemorrhage is usually caused by trauma and not by vascular pathology.
“Since SH is usually a result of trauma and not vascular pathology, it should be not be regarded as a VCD.”
The paper relies on this without support.
Subarachnoid hemorrhage is due to vascular pathology.
“SAH is due to vascular pathology and its associated cognitive deficits are appropriately regarded as VCD.”
The paper relies on this without support.
Incidental brain infarctions and white matter lesions are common in the brains of older individuals.
“Since incidental brain infarctions and WMLs are common in brains of older individuals, it is important to consider other possible etiologies when a cognitive disorder is present.”
The paper relies on this without support.
Microbleeds are not uncommon in cognitively normal older individuals.
“Since microbleeds are not uncommon in cognitively normal older individuals, attribution of the VCD to these, especially VaD, should follow a careful exclusion of other causes of cognitive impairment and only if numerous such lesions are present.”
The paper relies on this without support.
Vascular cognitive disorder is often associated with psychiatric or behavioral symptoms.
“VCD is often associated with psychiatric or behavioral symptoms that may pose special challenges for their treatment.”
The paper relies on this without support.
No single profile of depression or psychosis is specific to vascular cognitive disorder.
“While some attempts have been made to develop specific criteria for syndromes such as depression and psychosis associated with cognitive disorders,84 there is no one profile that is specific to VCD.”
The paper relies on this without support.
The heterogeneity of vascular cognitive disorder has made development of reliable non-imaging biomarkers extremely challenging.
“The heterogeneity of VCD has made the development of reliable non-imaging biomarkers extremely challenging.”
The paper relies on this without support.
None of the suggested cerebrospinal fluid biomarkers is specific to vascular cognitive disorder.
“As none of these is specific to VCD, they are not currently recommended for use for this diagnostic purpose.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Available diagnostic criteria vary with regard to sensitivity and specificity and are not interchangeable.
“However, available diagnostic criteria vary with regard to sensitivity and specificity and are, thus, not interchangeable. 3,18,22-25”
From Vascular Cognitive Impairment (2017) · cites this paper as [24]
Vascular dementia has seen a broadening of the concept to vascular cognitive impairment and dementia, and new diagnostic criteria have been proposed.
“Vascular dementia has seen a broadening of the concept to vascular cognitive impairment and dementia 156 , and new diagnostic criteria157, 158 have been proposed.”
From Mental health care for older adults: recent advances and new directions in clinical practice and research (2022) · cites this paper as [157]
In VASCOG, visuoconstructional-perceptual ability, praxisgnosis-body schema, and social cognition are additionally tested.
“In VASCOG, visuoconstructional-perceptual ability, praxisgnosis-body schema, and social cognition are additionally tested.”
From Progress toward standardized diagnosis of vascular cognitive impairment: Guidelines from the Vascular Impairment of Cognition Classification Consensus Study (2018) · cites this paper as [23]
The VASCOG criteria are aligned with the DSM-5.
“The VASCOG criteria are also aligned with the DSM-5 [23].”
From Progress toward standardized diagnosis of vascular cognitive impairment: Guidelines from the Vascular Impairment of Cognition Classification Consensus Study (2018) · cites this paper as [23]
Cites
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657 · see citing works
Self-citationAlbert, M. S., DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., Gamst, A., Holtzman, D. M., Jagust, W. J., Petersen, R. C., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.008 · Cited by 10,152 · see citing works
Wardlaw, J. M., Smith, E. E., Biessels, G. J., Cordonnier, C., Fazekas, F., Frayne, R., Lindley, R. I., O'Brien, J. T., Barkhof, F., Benavente, O. R., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70124-8 · Cited by 5,560 · see citing works
Self-citationWinblad, B., Palmer, K., Kivipelto, M., Jelic, V., Fratiglioni, L., Wahlund, L. ‐., Nordberg, A., Bäckman, L., Albert, M., Almkvist, O., et al. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01380.x · Cited by 4,946 · see citing works
Román, G. C., Tatemichi, T. K., Erkinjuntti, T., Cummings, J. L., Masdeu, J. C., Garcia, J. H., Amaducci, L., Orgogozo, J.-M., Brun, A., Hofman, A., et al. (1993) · Neurology · doi:10.1212/wnl.43.2.250 · Cited by 4,921 · see citing works
Self-citationBlessed, G., Tomlinson, B. E., & Roth, M. (1968) · British Journal of Psychiatry · doi:10.1192/bjp.114.512.797 · Cited by 4,117 · see citing works
Gorelick, P. B., Scuteri, A., Black, S. E., DeCarli, C., Greenberg, S. M., Iadecola, C., Launer, L. J., Laurent, S., Lopez, O. L., Nyenhuis, D., et al. (2011) · Stroke · doi:10.1161/str.0b013e3182299496 · Cited by 3,811 · see citing works
Self-citation. Cerebral blood flow in dementia.
Hachinski, V. C., Iliff, L. D., Zilhka, E., Du Boulay, G. H., McAllister, V. L., Marshall, J., Russell, R. W. R., & Symon, L. (1975) · Archives of Neurology · doi:10.1001/archneur.1975.00490510088009 · Cited by 3,186 · see citing works
Albert, M., DeKosky, S. T., Dickson, D. W., Dubois, B., Feldman, H., Fox, N. C., Gamst, A. C., Holtzman, D. M., Jagust, W. J., Petersen, R. C., et al. (2013) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.11.1.96 · Cited by 2,630 · see citing works
A New Rating Scale for Age-Related White Matter Changes Applicable to MRI and CT
Wahlund, L., Barkhof, F., Fazekas, F., Bronge, L. H., Augustin, M., Sjögren, M. J. C., Wallin, A., Adèr, H. J., Leys, D., Pantoni, L., et al. (2001) · Stroke · doi:10.1161/01.str.32.6.1318 · Cited by 1,797 · see citing works
Self-citationHachinski, V., Iadecola, C., Petersen, R. C., Breteler, M. M., Nyenhuis, D. L., Black, S. E., Powers, W. J., DeCarli, C., Merino, J. G., Kalaria, R. N., et al. (2006) · Stroke · doi:10.1161/01.str.0000237236.88823.47 · Cited by 1,722 · see citing works
Self-citationSnowdon, D. A. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540340047031 · Cited by 1,590 · see citing works
(2001) · The Lancet · doi:10.1016/s0140-6736(00)03589-3 · Cited by 1,338 · see citing works
Pathogenesis of Leukoaraiosis: A Review
Pantoni, L., & Garcia, J. H. (1997) · Stroke · doi:10.1161/01.str.28.3.652 · Cited by 1,225 · see citing works
Chui, H. C., Victoroff, J. I., Margolin, D., Jagust, W., Shankle, R., & Katzman, R. (1992) · Neurology · doi:10.1212/wnl.42.3.473 · Cited by 1,201 · see citing works
Self-citationO'Brien, J. T., Erkinjuntti, T., Reisberg, ., Román, G. C., Pantoni, L., Bowler, J., Ballard, C., DeCarli, C., Gorelick, P., Rockwood, K., et al. (2014) · International Journal of Stroke · doi:10.1111/ijs.12374_18 · Cited by 1,165 · see citing works
Self-citationO'Brien, J. T., Erkinjuntti, T., Reisberg, B., Roman, G., Sawada, T., Pantoni, L., Bowler, J. V., Ballard, C., DeCarli, C., Gorelick, P. B., et al. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00305-3 · Cited by 1,139 · see citing works
Self-citationMULTI-INFARCT DEMENTIA A CAUSE OF MENTAL DETERIORATION IN THE ELDERLY
HACHINSKI, V (1974) · The Lancet · doi:10.1016/s0140-6736(74)91496-2 · Cited by 1,093 · see citing works
Subcortical ischaemic vascular dementia
Román, G. C., Erkinjuntti, T., Wallin, A., Pantoni, L., & Chui, H. C. (2002) · The Lancet Neurology · doi:10.1016/s1474-4422(02)00190-4 · Cited by 1,067 · see citing works
Self-citationFisher (1965) · doi:10.1212/wnl.15.8.774 · Cited by 924 · see citing works
Toledo, J. B., Arnold, S. E., Raible, K., Brettschneider, J., Xie, S. X., Grossman, M., Monsell, S. E., Kukull, W. A., & Trojanowski, J. Q. (2013) · Brain · doi:10.1093/brain/awt188 · Cited by 849 · see citing works
Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics
de la Torre, J. C. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00683-0 · Cited by 834 · see citing works
Cordonnier, C., Al-Shahi Salman, R., & Wardlaw, J. (2007) · Brain · doi:10.1093/brain/awl387 · Cited by 703 · see citing works
MacLennan, R., & Jensen, O. M. (1977) · PubMed · Cited by 685 · see citing works
(2000) · PubMed · Cited by 683 · see citing works
Research criteria for subcortical vascular dementia in clinical trials
Erkinjuntti, T., Inzitari, D., Pantoni, L., Wallin, A., Scheltens, P., Rockwood, K. J., Román, G. C., Chui, H. C., & Desmond, D. W. (2000) · Springer eBooks · doi:10.1007/978-3-7091-6781-6_4 · Cited by 634 · see citing works
Self-citationAwad, I. A., Johnson, P. C., Spetzler, R. F., & Hodak, J. A. (1986) · Stroke · doi:10.1161/01.str.17.6.1090 · Cited by 572 · see citing works
DeCarli, C., Murphy, D. G. M., Tranh, M., Grady, C. L., Haxby, J. V., Gillette, J. A., Salerno, J. A., Gonzales-Aviles, A., Honvitz, B., Rapoport, S. I., et al. (1995) · Neurology · doi:10.1212/wnl.45.11.2077 · Cited by 531 · see citing works
White matter lesions impair frontal lobe function regardless of their location
Tullberg, M., Fletcher, E., DeCarli, C., Mungas, D., Reed, B. R., Harvey, D. J., Weiner, M. W., Chui, H. C., & Jagust, W. J. (2004) · Neurology · doi:10.1212/01.wnl.0000130530.55104.b5 · Cited by 530 · see citing works
Self-citationMoody, D. M., Bell, M. A., & CHALLA, V. R. (1990) · PubMed · Cited by 416 · see citing works
Vascular risk factors and dementia: How to move forward?
Viswanathan, A., Rocca, W. A., & Tzourio, C. (2009) · Neurology · doi:10.1212/01.wnl.0000341271.90478.8e · Cited by 414 · see citing works
Cognitive function, dementia and type 2 diabetes mellitus in the elderly
Strachan, M. W. J., Reynolds, R. M., Marioni, R. E., & Price, J. F. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.228 · Cited by 402 · see citing works
Differentiation of vascular dementia from AD on neuropsychological tests
Looi, J. C. L., & Sachdev, P. S. (1999) · Neurology · doi:10.1212/wnl.53.4.670 · Cited by 382 · see citing works
Self-citationBlack, S., Gao, F., & Bilbao, J. (2009) · Stroke · doi:10.1161/strokeaha.108.537704 · Cited by 379 · see citing works
Self-citationSenile Dementia of the Binswanger Type: A Vascular Form of Dementia in the Elderly
Román, G. C. (1987) · JAMA · doi:10.1001/jama.1987.03400130096040 · Cited by 372 · see citing works
Self-citationReview: sporadic cerebral amyloid angiopathy
Attems, J., Jellinger, K., Thal, D. R., & Van Nostrand, W. (2011) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2010.01137.x · Cited by 371 · see citing works
Self-citationZhu, Y.-C., Tzourio, C., Soumaré, A., Mazoyer, B., Dufouil, C., & Chabriat, H. (2010) · Stroke · doi:10.1161/strokeaha.110.591586 · Cited by 335 · see citing works
Pohjasvaara, T., Erkinjuntti, T., Vataja, R., & Kaste, M. (1997) · Stroke · doi:10.1161/01.str.28.4.785 · Cited by 328 · see citing works
The NIH Cognitive and Emotional Health Project: Report of the Critical Evaluation Study Committee
Hendrie, H. C., Albert, M. S., Butters, M. A., Gao, S., Knopman, D. S., Launer, L. J., Yaffe, K., Cuthbert, B. N., Edwards, E., & Wagster, M. V. (2006) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2005.11.004 · Cited by 323 · see citing works
Predictors and assessment of cognitive dysfunction resulting from ischaemic stroke.
Gottesman, R. F., & Hillis, A. E. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70164-2 · Cited by 319 · see citing works
Wen, W., & Sachdev, P. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2003.12.027 · Cited by 315 · see citing works
Self-citationClinical Determinants of Poststroke Dementia
Pohjasvaara, T., Erkinjuntti, T., Ylikoski, R., Hietanen, M., Vataja, R., & Kaste, M. (1998) · Stroke · doi:10.1161/01.str.29.1.75 · Cited by 315 · see citing works
Staging and natural history of cerebrovascular pathology in dementia
Deramecourt, V., Slade, J. Y., Oakley, A. E., Perry, R. H., Ince, P. G., Maurage, C.-A., & Kalaria, R. N. (2012) · Neurology · doi:10.1212/wnl.0b013e31824e8e7f · Cited by 309 · see citing works
Self-citationClinical determinants of dememtia related to stroke
Tatemichi, T. K., Desmond, D. W., Paik, M. C., Figueroa, M., Gropen, T., Stern, Y., Sano, M. C., Remien, R. H., Williams, J. B. W., Mohr, J. P., et al. (1993) · Annals of Neurology · doi:10.1002/ana.410330603 · Cited by 293 · see citing works
Towards defining the neuropathological substrates of vascular dementia
Kalaria, R. N., Kenny, R. A., Ballard, C. G., Perry, R., Ince, P., & Polvikoski, T. (2004) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.09.019 · Cited by 291 · see citing works
Self-citationThe thalamus and behavior: Effects of anatomically distinct strokes
Carrera, E., & Bogousslavsky, J. (2006) · Neurology · doi:10.1212/01.wnl.0000219679.95223.4c · Cited by 290 · see citing works
Wetterling, T., Kanitz, R.-D., & Borgis, K.-J. (1996) · Stroke · doi:10.1161/01.str.27.1.30 · Cited by 266 · see citing works
Yue, N. C., Arnold, A. M., Longstreth, W. T., Jr., Elster, A. D., Jungreis, C. A., O’Leary, D. H., Poirier, V. C., & Bryan, R. N. (1997) · Radiology · doi:10.1148/radiology.202.1.8988189 · Cited by 237 · see citing works
Vascular determinants of cholinergic deficits in Alzheimer disease and vascular dementia.
Román, G. C., & Kalaria, R. N. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.10.004 · Cited by 213 · see citing works
Self-citationGoos, J. D. C., Kester, M. I., Barkhof, F., Klein, M., Blankenstein, M. A., Scheltens, P., & van der Flier, W. M. (2009) · Stroke · doi:10.1161/strokeaha.109.558197 · Cited by 213 · see citing works
Self-citationWen, W., Sachdev, P. S., Li, J. J., Chen, X., & Anstey, K. J. (2009) · Human Brain Mapping · doi:10.1002/hbm.20586 · Cited by 210 · see citing works
Self-citationDo white matter changes on MRI and CT differentiate vascular dementia from Alzheimer's disease?
Erkinjuntti, T., Ketonen, L., Sulkava, R. O., Sipponen, J. T., Vuorialho, M., & Iivanainen, M. (1987) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.50.1.37 · Cited by 196 · see citing works
Price, C. C., Jefferson, A. L., Merino, J. G., Heilman, K. M., & Libon, D. J. (2005) · Neurology · doi:10.1212/01.wnl.0000168877.06011.15 · Cited by 191 · see citing works
Cardiovascular Risk Factors and Incident Alzheimer Disease: A Systematic Review of the Literature
Purnell, C., Gao, S., Callahan, C. M., & Hendrie, H. C. (2009) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e318187541c · Cited by 189 · see citing works
Identification of pure subcortical vascular dementia using <sup>11</sup> C-Pittsburgh compound B
Lee, J. H., Kim, S. H., Kim, G. H., Seo, S. W., Park, H. K., Oh, S. J., Kim, J. S., Cheong, H. K., & Na, D. L. (2011) · Neurology · doi:10.1212/wnl.0b013e318221acee · Cited by 179 · see citing works
Hachinski, V. C., Bowler, J. V., & Loeb, C. (1993) · Neurology · doi:10.1212/wnl.43.10.2159-a · Cited by 171 · see citing works
. Identification of Alzheimer and vascular lesion thresholds for mixed dementia.
Gold, G., Giannakopoulos, P., Herrmann, F. R., Bouras, C., & Kovari, E. (2007) · Brain · doi:10.1093/brain/awm228 · Cited by 163 · see citing works
Brown, W. R., Moody, D. M., Thore, C. R., Challa, V. R., & Anstrom, J. A. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.01.015 · Cited by 162 · see citing works
Nitkunan, A., Barrick, T. R., Charlton, R. A., Clark, C. A., & Markus, H. S. (2008) · Stroke · doi:10.1161/strokeaha.107.507475 · Cited by 153 · see citing works
Merino, J. G., & Warach, S. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.129 · Cited by 152 · see citing works
Morphologic diagnosis of “vascular dementia” — A critical update
Jellinger, K. A. (2008) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.03.006 · Cited by 150 · see citing works
Self-citationCerebral microbleeds and vascular cognitive impairment.
Werring, D. J., Gregoire, S. M., & Cipolotti, L. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2010.08.034 · Cited by 143 · see citing works
Review: Molecular genetics and pathology of hereditary small vessel diseases of the brain
Yamamoto, Y., Craggs, L., Baumann, M., Kalimo, H., & Kalaria, R. N. (2011) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2010.01147.x · Cited by 125 · see citing works
Self-citationTartaglia, M. C., Rosen, H. J., & Miller, B. L. (2011) · Neurotherapeutics · doi:10.1007/s13311-010-0012-2 · Cited by 124 · see citing works
Mononeuritis and cryoglobulins
Strieker, R. B., & KIPROV, D. D. (1993) · Neurology · doi:10.1212/wnl.43.10.2159 · Cited by 99 · see citing works
Pathogenesis of vascular dementia in stroke-prone spontaneously hypertensive rats
Kimura, S., Saito, H., Minami, M., Togashi, H., Nakamura, N., Nemoto, M., & Parvez, H. S. (2000) · Toxicology · doi:10.1016/s0300-483x(00)00312-7 · Cited by 97 · see citing works
. Prevalence, incidence, and risk factors of lacunar infarcts in a community sample.
Chen, X., Wen, W., Anstey, K. J., & Sachdev, P. S. (2009) · Neurology · doi:10.1212/wnl.0b013e3181aa52ea · Cited by 76 · see citing works
Self-citationVascular aspects in Alzheimer’s disease
Skoog, I. (2000) · Advances in Dementia Research · doi:10.1007/978-3-7091-6781-6_6 · Cited by 71 · see citing works
Self-citationReversible dementia in patients with chronic subdural hematomas
Ishikawa, E., Yanaka, K., Sugimoto, K., Ayuzawa, S., & Nose, T. (2002) · Journal of Neurosurgery · doi:10.3171/jns.2002.96.4.0680 · Cited by 70 · see citing works
Homocysteine as a Risk Factor for Cognitive Impairment in Stroke Patients
Sachdev, P. S., Valenzuela, M., Brodaty, H., Wang, X. L., Looi, J. C., Lorentz, L., Howard, L., Jones, M., Zagami, A. S., Gillies, D., et al. (2003) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000068481 · Cited by 67 · see citing works
Self-citationLoss of Cholinergic Pathways in Vascular Dementia of the Binswanger Type
Tomimoto, H., Ohtani, R., Shibata, M., Nakamura, N., & Ihara, M. (2005) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000084553 · Cited by 66 · see citing works
Jeste, D. V., Meeks, T. W., Kim, D. S., & Zubenko, G. S. (2006) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988706291087 · Cited by 59 · see citing works
Self-citationLiman, T., Heuschmann, P. U., Endres, M., Flöel, A., Schwab, S., & Kolominsky‐Rabas, P. L. (2011) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000327358 · Cited by 55 · see citing works
. Pittsburgh compound B binding in poststroke dementia.
Mok, V., Leung, E. Y. L., Chu, W., Chen, S., Wong, A., Xiong, Y., Lam, W., Ho, C. L., & Wong, K. S. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.12.014 · Cited by 52 · see citing works
Vascular cognitive impairment: Today and tomorrow
Chui, H. C. (2006) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2006.03.003 · Cited by 44 · see citing works
Self-citationSwartz, R. H., & Black, S. E. (2006) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.091561 · Cited by 44 · see citing works
Self-citation(1983) · Journal of Neurosurgery · doi:10.3171/jns.1983.59.3.0550 · Cited by 29 · see citing works
Is It Time to Retire the Term “Dementia”?
Sachdev, P. (2000) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.12.2.276 · Cited by 26 · see citing works
Self-citationBrain imaging in stroke: insight beyond diagnosis.
Nour, M., & Liebeskind, D. S. (2011) · Neurotherapeutics · doi:10.1007/s13311-011-0046-0 · Cited by 15 · see citing works
Uncommon causes of cerebrovascular dementia.
Starkstein, S. E., Jorge, R., & Capizzano, A. A. (2005) · International Psychogeriatrics · doi:10.1017/s1041610205001948 · Cited by 10 · see citing works
Sachdev (1999) · doi:10.1002/(sici)1099-1166(199905)14:5
Self-citation
Flagged first, then by citations
7 of the 88 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Skoog, 2000, Vascular aspects in Alzheimers disease., J Neural Transm Suppl, 59, 37
Cited by
Sorted by citations
Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5)
Ma, F. (2020) · Springer eBooks · doi:10.1007/978-3-319-69892-2_419-2 · Cited by 1,241 · see citing works
O'Brien, J. T., & Thomas, A. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00463-8 · Cited by 1,136 · see citing works
Self-citationClassifying neurocognitive disorders: the DSM-5 approach
Sachdev, P. S., Blacker, D., Blazer, D. G., Ganguli, M., Jeste, D. V., Paulsen, J. S., & Petersen, R. C. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.181 · Cited by 1,116 · see citing works
Self-citationRegulation of cerebral blood flow in humans: physiology and clinical implications of autoregulation
Claassen, J. A. H. R., Thijssen, D. H. J., Panerai, R. B., & Faraci, F. M. (2021) · Physiological Reviews · doi:10.1152/physrev.00022.2020 · Cited by 947 · see citing works
Post-Stroke Cognitive Impairment and Dementia
Rost, N. S., Brodtmann, A. G., Pase, M. P., van Veluw, S. J., Biffi, A., Duering, M., Hinman, J. D., & Dichgans, M. (2022) · Circulation Research · doi:10.1161/circresaha.122.319951 · Cited by 837 · see citing works
Stroke injury, cognitive impairment and vascular dementia
Kalaria, R. N., Akinyemi, R., & Ihara, M. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.01.015 · Cited by 647 · see citing works
Self-citationvan der Flier, W. M., Skoog, I. G., Schneider, J. A., Pantoni, L., Mok, V., Chen, C., & Scheltens, P. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.3 · Cited by 600 · see citing works
Self-citationEpidemiology of stroke in Europe and trends for the 21st century
Béjot, Y., Bailly, H., Durier, J., & Giroud, M. (2016) · La Presse Médicale · doi:10.1016/j.lpm.2016.10.003 · Cited by 510 · see citing works
Biobank, O. B. O. D. P. U. A. U., Wilkinson, T., Schnier, C., Bush, K., Rannikmäe, K., Henshall, D. E., Lerpiniere, C., Allen, N. E., Flaig, R., Russ, T. C., et al. (2019) · European Journal of Epidemiology · doi:10.1007/s10654-019-00499-1 · Cited by 452 · see citing works
Self-citationAlber, J., Alladi, S., Bae, H., Barton, D. A., Beckett, L. A., Bell, J. M., Berman, S. E., Biessels, G. J., Black, S. E., Bos, I., et al. (2019) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1016/j.trci.2019.02.001 · Cited by 440 · see citing works
Self-citationReynolds, C. F., Jeste, D. V., Sachdev, P. S., & Blazer, D. G. (2022) · World Psychiatry · doi:10.1002/wps.20996 · Cited by 465 · see citing works
Self-citationKalaria, R. N. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1571-z · Cited by 441 · see citing works
Self-citationA clinicopathological approach to the diagnosis of dementia
Elahi, F. M., & Miller, B. L. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.96 · Cited by 407 · see citing works
Skrobot, O. A., Black, S. E., Chen, C., DeCarli, C., Erkinjuntti, T., Ford, G. A., Kalaria, R. N., O'Brien, J., Pantoni, L., Pasquier, F., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.09.007 · Cited by 431 · see citing works
Self-citationDiagnostic and Statistical Manual of Mental Disorders-5 (DSM-5)
Ma, F. (2021) · Springer eBooks · doi:10.1007/978-3-030-22009-9_419 · Cited by 427 · see citing works
O'Brien, J. T., Holmes, C., Jones, M. S., Jones, R. W., Livingston, G., McKeith, I. G., Mittler, P. J., Passmore, P., Ritchie, C. W., Robinson, L. A., et al. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881116680924 · Cited by 355 · see citing works
Self-citationThe pathology and pathophysiology of vascular dementia
Kalaria, R. N. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.12.030 · Cited by 344 · see citing works
Self-citationKatz, D. I., Bernick, C. B., Dodick, D. W., Mez, J. B., Mariani, M. L., Adler, C. H., Alosco, M. L., Balcer, L. J., Banks, S. J., Barr, W., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000011850 · Cited by 345 · see citing works
Weaver, N. A., Kuijf, H. J., Aben, H. P., et al. (2021) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00060-0 · Cited by 316 · see citing works
Self-citationLewczuk, P., Riederer, P. F., O’Bryant, S. E., Verbeek, M. M., Dubois, B., Visser, P. J., Jellinger, K. A., Engelborghs, S., Ramı́rez, A., Parnetti, L., et al. (2017) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2017.1375556 · Cited by 308 · see citing works
Self-citationVascular Cognitive Impairment (VCI)
Rundek, T., Tolea, M. I., Ariko, T., Fagerli, E. A., & Camargo, C. J. (2021) · Neurotherapeutics · doi:10.1007/s13311-021-01170-y · Cited by 325 · see citing works
Imaging retina to study dementia and stroke
Cheung, C. Y.-L., Ikram, M. K., Chen, C., & Wong, T. Y. (2017) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.01.001 · Cited by 276 · see citing works
Self-citationHussain, B., Fang, C., & Chang, J. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.688090 · Cited by 251 · see citing works
Clinical presentations and epidemiology of vascular dementia
Smith, E. E. (2017) · Clinical Science · doi:10.1042/cs20160607 · Cited by 250 · see citing works
The Vascular Impairment of Cognition Classification Consensus Study
Skrobot, O. A., O'Brien, J., Black, S., Chen, C., DeCarli, C., Erkinjuntti, T., Ford, G. A., Kalaria, R. N., Pantoni, L., Pasquier, F., et al. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.10.007 · Cited by 242 · see citing works
Self-citationZloković, B. V., Gottesman, R. F., Bernstein, K. E., Seshadri, S. S., McKee, A. C., Snyder, H. M., Greenberg, S. M., Yaffe, K. S., Schaffer, C. B., Yuan, C., et al. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12157 · Cited by 241 · see citing works
Zhang, X., Wei, M., Fan, J., Yan, W., Zha, X., Song, H., Wan, R., Yin, Y., & Wang, W. (2020) · Autophagy · doi:10.1080/15548627.2020.1840796 · Cited by 229 · see citing works
Lanctôt, K. L., Lindsay, M. P., Smith, E. E., Sahlas, D. J., Foley, N. C., Gubitz, G. J., Austin, M., Ball, K., Bhogal, S. K., Blake, T. M., et al. (2019) · International Journal of Stroke · doi:10.1177/1747493019847334 · Cited by 238 · see citing works
Rajeev, V., Chai, Y. L., Poh, L., Selvaraji, S., Fann, D. Y., Jo, D., Silva, T. M. D., Drummond, G. R., Sobey, C. G., Arumugam, T. V., et al. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01590-1 · Cited by 237 · see citing works
Self-citationHamilton, O. K., Backhouse, E. V., Janssen, E., Jochems, A. C. C., Maher, C., Ritakari, T. E., Stevenson, A. J., Xia, L., Deary, I. J., & Wardlaw, J. M. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12221 · Cited by 204 · see citing works
Atrial Fibrillation and Dementia: A Report From the AF-SCREEN International Collaboration
Rivard, L., Friberg, L., Conen, D., Healey, J. S., Berge, T., Boriani, G., Brandes, A., Calkins, H., Camm, A. J., Chen, L. Y., et al. (2022) · Circulation · doi:10.1161/circulationaha.121.055018 · Cited by 214 · see citing works
The Quick Dementia Rating System (QDRS): A rapid dementia staging tool
Galvin, J. E. (2015) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2015.03.003 · Cited by 200 · see citing works
Jiao, B., Li, R., Zhou, H., Qing, K., Liu, H., Pan, H., Lei, Y., Fu, W., Wang, X., Xiao, X., et al. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01181-1 · Cited by 216 · see citing works
Cerebral small vessel disease and vascular cognitive impairment: from diagnosis to management
Zotin, M. C. Z., Sveikata, L., Viswanathan, A., & Yilmaz, P. (2021) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000913 · Cited by 203 · see citing works
Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5)
Ma, F. (2020) · Springer eBooks · doi:10.1007/978-3-319-69892-2_419-1 · Cited by 186 · see citing works
The role of inflammasomes in vascular cognitive impairment
Poh, L., Sim, W. L., Jo, D., Dinh, Q. N., Drummond, G. R., Sobey, C. G., Chen, C., Lai, M. K. P., Fann, D. Y., & Arumugam, T. V. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00506-8 · Cited by 167 · see citing works
Self-citationPast, present and future role of retinal imaging in neurodegenerative disease
Kashani, A. H., Asanad, S., Chan, J. W., Singer, M., Zhang, J., Sharifi, M., Khansari, M. M., Abdolahi, F., Shi, Y., Biffi, A., et al. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2020.100938 · Cited by 164 · see citing works
Self-citationChallenges of multimorbidity of the aging brain: a critical update
Jellinger, K. A., & Attems, J. (2015) · Journal of Neural Transmission · doi:10.1007/s00702-014-1288-x · Cited by 154 · see citing works
Self-citationMolecular biomarkers for vascular cognitive impairment and dementia
Hosoki, S., Hansra, G. K., Jayasena, T., Poljak, A., Mather, K. A., Catts, V. S., Rust, R., Sagare, A. P., Kovacic, J. C., Brodtmann, A. G., et al. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-023-00884-1 · Cited by 166 · see citing works
Self-citationIs Alzheimer’s Disease Risk Modifiable?
Serrano‐Pozo, A., & Growdon, J. H. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad181028 · Cited by 157 · see citing works
Pharmacotherapy for Vascular Cognitive Impairment
Farooq, M. U., Min, J., Goshgarian, C., & Gorelick, P. B. (2017) · CNS Drugs · doi:10.1007/s40263-017-0459-3 · Cited by 152 · see citing works
Vascular Cognitive Impairment and Dementia
Wong, E. C., & Chui, H. C. (2022) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000001124 · Cited by 158 · see citing works
Self-citationBarbay, M., Diouf, M., Roussel, M., Godefroy, O., & GRECOGVASC study group (2018) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000492920 · Cited by 142 · see citing works
Mixed dementia: A review of the evidence
Custodio, N., Montesinos, R., Lira, D., Herrera-Pérez, E., Bardales, Y., & Valeriano-Lorenzo, L. (2017) · Dementia & Neuropsychologia · doi:10.1590/1980-57642016dn11-040005 · Cited by 148 · see citing works
Barbagallo, C., Mostile, G., Baglieri, G., Giunta, F., Luca, A., Raciti, L., Zappia, M., Purrello, M., Ragusa, M., & Nicoletti, A. S. Q. (2019) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-019-00751-y · Cited by 144 · see citing works
Post-mortem assessment in vascular dementia: advances and aspirations
McAleese, K. E., Alafuzoff, I. I., Charidimou, A., Reuck, J. D., Grinberg, L. T., Hainsworth, A. H., Hortobágyi, T., Ince, P. G., Jellinger, K. A., Gao, J., et al. (2016) · BMC Medicine · doi:10.1186/s12916-016-0676-5 · Cited by 139 · see citing works
Self-citationKarikari, T. K., Emeršič, A., Vrillon, A., Lantero‐Rodriguez, J., Ashton, N. J., Kramberger, M. G., Dumurgier, J., Hourregue, C., Čučnik, S., Brinkmalm, G., et al. (2021) · Alzheimer's & Dementia · doi:10.1002/alz.12236 · Cited by 143 · see citing works
Associations between amyloid β and white matter hyperintensities: A systematic review
Roseborough, A. D., Ramirez, J., Black, S. E., & Edwards, J. D. (2017) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2017.01.026 · Cited by 134 · see citing works
Self-citationTrial of pimavanserin in dementia-related psychosis
Tariot, P. N., Cummings, J. L., Soto-Martin, M. E., Ballard, C., Erten-Lyons, D., Sultzer, D. L., Devanand, D. P., Weintraub, D., McEvoy, B., Youakim, J. M., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2034634 · Cited by 145 · see citing works
Tedaldi, E., Minniti, N. L., & Fischer, T. (2015) · BioMed Research International · doi:10.1155/2015/641913 · Cited by 134 · see citing works
Update on Vascular Cognitive Impairment Associated with Subcortical Small-Vessel Disease
Wallin, A., Román, G. C., Esiri, M. M., Kettunen, P., Svensson, J., Paraskevas, G. P., & Kapaki, E. N. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170803 · Cited by 130 · see citing works
Self-citationAzam, S., Haque, M. E., Jakaria, M., Jo, S.-H., Kim, I., & Choi, D. (2020) · Cells · doi:10.3390/cells9020506 · Cited by 124 · see citing works
Khan, A., Kalaria, R. N., Corbett, A., & Ballard, C. G. (2016) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988716654987 · Cited by 125 · see citing works
Self-citationCognitive Impairment and Dementia After Stroke: Design and Rationale for the DISCOVERY Study
Rost, N. S., Meschia, J. F., Gottesman, R. F., Wruck, L. M., Helmer, K. G., Greenberg, S. M., on behalf of the DISCOVERY Investigators*, Barrett, K. M., Biffi, A., Boden-Albala, B. M., et al. (2021) · Stroke · doi:10.1161/strokeaha.120.031611 · Cited by 134 · see citing works
Wang, B., Lei, M., Shen, T., Jie, L. T., Qian, L., Lin, F., & Wang, P. (2018) · Clinical Rehabilitation · doi:10.1177/0269215518791007 · Cited by 112 · see citing works
Llorens, F., Hermann, P., Villar‐Piqué, A., Lucena, D. D., Nägga, K., Hansson, O., Santana, I. J., Schmitz, M., Schmidt, C., Varges, D., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14373-2 · Cited by 114 · see citing works
Blood Pressure and Risk of Vascular Dementia
Emdin, C. A., Rothwell, P. M., Salimi‐Khorshidi, G., Kiran, A., Conrad, N., Callender, T., Mehta, Z., Pendlebury, S. T., Anderson, S. G., Mohseni, H., et al. (2016) · Stroke · doi:10.1161/strokeaha.116.012658 · Cited by 113 · see citing works
Cipollini, V., Troili, F., & Giubilei, F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112812 · Cited by 98 · see citing works
The role of GPCRs in neurodegenerative diseases: avenues for therapeutic intervention
Huang, Y., Todd, N., & Thathiah, A. (2017) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2017.02.001 · Cited by 99 · see citing works
METACOHORTS Consortium, Dichgans, M., Wardlaw, J., Smith, E., Zietemann, V., Seshadri, S., Sachdev, P., Biessels, G. J., Fazekas, F., Benavente, O., et al. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.06.004 · Cited by 101 · see citing works
Self-citationPark, M., & Moon, W. (2016) · Korean Journal of Radiology · doi:10.3348/kjr.2016.17.6.827 · Cited by 101 · see citing works
Barbay, M., Taillia, H., Nédélec-Ciceri, C., Bompaire, F., Bonnin, C. A., Varvat, J., Vincent-Grangette, F., Diouf, M., Wiener, E., Mas, J., et al. (2018) · Stroke · doi:10.1161/strokeaha.117.018889 · Cited by 98 · see citing works
New insights into cerebral small vessel disease and vascular cognitive impairment from MRI
Smith, E. E., & Beaudin, A. E. (2017) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000513 · Cited by 90 · see citing works
Stroke, cerebrovascular diseases and vascular cognitive impairment in Africa
Akinyemi, R., Owolabi, M. O., Ihara, M., Damasceno, A. A. M., Ogunniyi, A. O., Dotchin, C. L., Paddick, S., Ogeng’o, J. A., Walker, R. W., & Kalaria, R. N. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.05.018 · Cited by 98 · see citing works
Self-citationPathoconnectomics of cognitive impairment in small vessel disease: A systematic review
Dey, A., Stamenova, V., Turner, G. R., Black, S. E., & Levine, B. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.01.007 · Cited by 96 · see citing works
Self-citationPrediction of post-stroke cognitive impairment after acute ischemic stroke using machine learning
Lee, M., Yeo, N. Y., Ahn, H.-J., Lim, J., Kim, Y., Lee, S., Oh, M. S., Lee, B., Yu, K., & Kim, C. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01289-4 · Cited by 106 · see citing works
The Role of Neuropsychiatric Symptoms in Research Diagnostic Criteria for Neurodegenerative Diseases
Cummings, J. (2021) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2020.07.011 · Cited by 96 · see citing works
DSM-5 and Mental Disorders in Older Individuals
Sachdev, P. S., Mohan, A., Taylor, L., & Jeste, D. V. (2015) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000090 · Cited by 98 · see citing works
Self-citationExtra-virgin olive oil for potential prevention of Alzheimer disease
Román, G. C., Jackson, R. E., Reis, J. J., Roman, A., Toledo, J. B., & Toledo, E. (2019) · Revue Neurologique · doi:10.1016/j.neurol.2019.07.017 · Cited by 91 · see citing works
Self-citationMcDonald, M. W., Black, S. E., Copland, D. A., Corbett, D., Dijkhuizen, R. M., Farr, T. D., Jeffers, M. S., Kalaria, R. N., Karayanidis, F., Leff, A. P., et al. (2019) · International Journal of Stroke · doi:10.1177/1747493019873600 · Cited by 92 · see citing works
Self-citationAndré, S., Heinrich, S., Kayser, F., Menzler, K., Kesselring, J., Khader, P. H., Lefaucheur, J., & Mylius, V. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.07.065 · Cited by 89 · see citing works
Chu, N. M., Hong, J., Harasemiw, O., Chen, X., Fowler, K. J., Dasgupta, I., Bohm, C. J., Segev, D. L., McAdams‐DeMarco, M., & the Global Renal Exercise Network (2021) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfab338 · Cited by 90 · see citing works
Dissection of synaptic pathways through the CSF biomarkers for predicting Alzheimer disease
Tible, M., Sandelius, Å., Höglund, K., Brinkmalm, A., Cognat, E., Dumurgier, J., Zetterberg, H., Hugon, J., Paquet, C., & Blennow, K. (2020) · Neurology · doi:10.1212/wnl.0000000000010131 · Cited by 83 · see citing works
Benussi, A., Grassi, M., Palluzzi, F., Koch, G., di Lazzaro, V., Nardone, R., Cantoni, V., dell'Era, V., Premi, E., Martorana, A., et al. (2020) · Annals of Neurology · doi:10.1002/ana.25677 · Cited by 82 · see citing works
Cerebral amyloid angiopathy as a cause of neurodegeneration
Smith, E. E. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14157 · Cited by 86 · see citing works
Čermáková, P., Lund, L. H., Fereshtehnejad, S., Johnell, K., Winblad, B. G., Dahlström, U., Eriksdotter, M., & Religa, D. (2015) · European Journal of Heart Failure · doi:10.1002/ejhf.222 · Cited by 88 · see citing works
Levit, A., Hachinski, V., & Whitehead, S. N. (2020) · GeroScience · doi:10.1007/s11357-020-00164-6 · Cited by 89 · see citing works
Framework for Clinical Trials in Cerebral Small Vessel Disease (FINESSE)
Markus, H. S., van der Flier, W. M., Smith, E. E., Bath, P. M., Biessels, G. J., Briceño, E. M., Brodtman, A., Chabriat, H., Chen, C., de Leeuw, F., et al. (2022) · JAMA Neurology · doi:10.1001/jamaneurol.2022.2262 · Cited by 87 · see citing works
Self-citationLin, Y., Wang, K., Ma, C., Wang, X., Gong, Z., Zhang, R., Zang, D., & Cheng, Y. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00227 · Cited by 87 · see citing works
Pimavanserin: Potential Treatment For Dementia-Related Psychosis
Cummings, J. L., Ballard, C. G., Tariot, P. N., Owen, R., Foff, E. P., Youakim, J. M., Norton, J., & Stankovic, S. (2018) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2018.29 · Cited by 89 · see citing works
Khaw, J., Subramaniam, P., Aziz, N. A. A., Raymond, A. A., Zaidi, W. A. W., & Ghazali, S. E. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18178962 · Cited by 87 · see citing works
Musaeus, C. S., Gleerup, H. S., Høgh, P., Waldemar, G., Hasselbalch, S. G., & Simonsen, A. H. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200168 · Cited by 85 · see citing works
Improving the clinical detection of Lewy body dementia with the Lewy body composite risk score
Galvin, J. E. (2015) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2015.05.004 · Cited by 87 · see citing works
Moodley, K. K., Minati, L., Contarino, V. E., Prioni, S., Wood, R., Cooper, R., D’Incerti, L., Tagliavini, F., & Chan, D. (2015) · Hippocampus · doi:10.1002/hipo.22417 · Cited by 79 · see citing works
Zhu, H.-Y., Hong, F.-F., & Yang, S.-L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094540 · Cited by 84 · see citing works
Neuroimaging Determinants of Poststroke Cognitive Performance
Puy, L., Barbay, M., Roussel, M., Canaple, S., Lamy, C., Arnoux, A., Leclercq, C., Mas, J., Tasseel‐Ponche, S., Constans, J., et al. (2018) · Stroke · doi:10.1161/strokeaha.118.021981 · Cited by 80 · see citing works
Pharmacological Treatment of Vascular Dementia: A Molecular Mechanism Perspective
Kuang, H., Zhou, Z., Zhu, Y., Wan, Z., Yang, M.-W., Hong, F., & Yang, S. (2021) · Aging and Disease · doi:10.14336/ad.2020.0427 · Cited by 83 · see citing works
Alzheimer’s/Vascular Spectrum Dementia: Classification in Addition to Diagnosis
Emrani, S., Lamar, M., Price, C. C., Wasserman, V., Matusz, E. F., Au, R., Swenson, R. A., Nagele, R. G., Heilman, K. M., & Libon, D. J. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190654 · Cited by 76 · see citing works
Clinical practice guideline for cognitive impairment of cerebral small vessel disease
Peng, D., & Geriatric Neurology Group, C. S. O. G. (2019) · Aging Medicine · doi:10.1002/agm2.12073 · Cited by 75 · see citing works
Verdelho, A., Wardlaw, J. M., Pavlovic, A. M., Pantoni, L., Godefroy, O., Duering, M., Charidimou, A., Chabriat, H., & Biessels, G. J. (2021) · European Stroke Journal · doi:10.1177/23969873211000258 · Cited by 74 · see citing works
Luca, M., & Luca, A. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/8067045 · Cited by 71 · see citing works
Advances in Management of Neuropsychiatric Syndromes in Neurodegenerative Diseases
Cummings, J. L., Ritter, A. R., & Rothenberg, K. G. (2019) · Current Psychiatry Reports · doi:10.1007/s11920-019-1058-4 · Cited by 69 · see citing works
Transcranial Doppler ultrasound in vascular cognitive impairment-no dementia
Vinciguerra, L., Lanza, G., Puglisi, V., Pennisi, M., Cantone, M., Bramanti, A., Pennisi, G., & Bella, R. (2019) · PLoS ONE · doi:10.1371/journal.pone.0216162 · Cited by 66 · see citing works
Thingstad, P., Askim, T., Beyer, M. K., Bråthen, G., Ellekjær, H., Ihle‐Hansen, H., Knapskog, A., Lydersen, S., Munthe‐Kaas, R., Næss, H., et al. (2018) · BMC Neurology · doi:10.1186/s12883-018-1198-x · Cited by 64 · see citing works
Atri, A., Dickerson, B. C., Clevenger, C. K., Karlawish, J. H., Knopman, D. S., Lin, P., Norman, M., Onyike, C. U., Sano, M., Scanland, S., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14333 · Cited by 77 · see citing works
Clinical Guidelines for Cognitive Disorders in Elderly and Older Patients
Bogolepova, A. N., Васенина, Е. Е., Gomzyakova, N. A., Gusev, E. I., Dudchenko, N. G., Emelin, А. Y., Zalutskaya, N. M., Isaev, R. I., Kotovskaya, Y. V., Levin, O. S., et al. (2021) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro20211211036 · Cited by 72 · see citing works
Lower cerebral blood flow predicts cognitive decline in patients with vascular cognitive impairment
van Dinther, M., Hooghiemstra, A. M., Bron, E. E., Versteeg, A., Leeuwis, A. E., Kalay, T., Moonen, J. E. F., Kuipers, S., Backes, W. H., Jansen, J. F. A., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13408 · Cited by 67 · see citing works
Neuroimaging in Vascular Cognitive Impairment and Dementia: A Systematic Review
Frantellizzi, V., Pani, A., Ricci, M., Locuratolo, N., Fattapposta, F., & Vincentis, G. D. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191046 · Cited by 67 · see citing works
Graff‐Radford, J. (2019) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000684 · Cited by 80 · see citing works
Mayeda, E. R. (2019) · American Journal of Epidemiology · doi:10.1093/aje/kwz047 · Cited by 52 · see citing works
- Authors
- Sachdev, P., Kalaria, R., O’Brien, J., Skoog, I., Alladi, S., Black, S. E., Blacker, D., Blazer, D. G., Chen, C., Chui, H., Ganguli, M., Jellinger, K., Jeste, D. V., Pasquier, F., Paulsen, J., Prins, N., Rockwood, K., Roman, G., & Scheltens, P.
- Affiliations
- University of Southern California (US)
- Newcastle University (GB)
- University of Gothenburg (SE)
- Nizam's Institute of Medical Sciences (IN)
- Sunnybrook Health Science Centre (CA)
- UNSW Sydney (AU)
- Prince of Wales Hospital (AU)
- University of Cambridge (GB)
- Corresponding author
- Sachdev, Perminder
- Blacker, Deborah
- Pasquier, Florence
- ORCID
- Venue
- Alzheimer Disease & Associated Disorders
- Published
- 2014-07
- Volume
- 28
- Issue
- 3
- Pages
- 206-218
- ISSN
- 0893-0341 (ISSN-L)
- PMC
- PMC4139434
- OpenAlex
- W2035892177
- Cited by
- 852
- References
- 88
- Citations by year
- 2026: 94 · 2025: 106 · 2024: 97 · 2023: 75 · 2022: 72 · 2021: 98 · 2020: 75 · 2019: 81 · 2018: 43 · 2017: 46 · 2016: 35 · 2015: 22 · 2014: 7 · 2013: 1
- FWCI
- 27.97
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Alzheimer Disease & Associated Disorders (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- PubMed Central (acceptedVersion)
- UNSWorks (UNSW Sydney) (submittedVersion, cc-by-nc-nd)
- eScholarship (California Digital Library) (submittedVersion)
- UNSWorks (University of New South Wales, Sydney, Australia) (submittedVersion, cc-by-nc-nd)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Medical Research Council (MR/L016451/1)
- Australian Research Council (DP120102078)
- NIHR Newcastle Biomedical Research Centre (BH111030)
- National Institute on Aging (P50AG005142, P50AG005134, K07AG044395, P30AG062421)
- National Institute of Mental Health (R01MH071536)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Social Sciences › Psychology › Clinical Psychology › Historical and Modern Theater Studies
- Keywords
- vascular dementia, diagnostic criteria, vascular etiology, Alzheimer disease pathology, DSM-5
- MeSH terms
- Cognition Disorders, Humans, Dementia, Vascular
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-04.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-04.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review